Casdin Capital, LLC Standard Biotools Inc. Transaction History
Casdin Capital, LLC
- $734 Million
- Q3 2025
A detailed history of Casdin Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 77,558,856 shares of LAB stock, worth $96.2 Million. This represents 13.74% of its overall portfolio holdings.
Number of Shares
77,558,856
Previous 76,075,636
1.95%
Holding current value
$96.2 Million
Previous $91.3 Million
10.45%
% of portfolio
13.74%
Previous 12.8%
Shares
6 transactions
Others Institutions Holding LAB
# of Institutions
163Shares Held
284MCall Options Held
59.7KPut Options Held
18.7K-
Viking Global Investors LP58.7MShares$72.7 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$27 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$21.4 Million0.0% of portfolio
-
Mak Capital One LLC New York, NY15.9MShares$19.8 Million3.18% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.4MShares$14.1 Million0.55% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $97.5M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...